The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis.
Terawaki Y, Nomiyama T, Akehi Y, Takenoshita H, Nagaishi R, Tsutsumi Y, Murase K, Nagasako H, Hamanoue N, Sugimoto K, Takada A, Ito K, Abe Y, Sasatomi Y, Ogahara S, Nakashima H, Saito T, Yanase T.
Terawaki Y, et al. Among authors: tsutsumi y.
Diabetol Metab Syndr. 2013 Feb 28;5(1):10. doi: 10.1186/1758-5996-5-10.
Diabetol Metab Syndr. 2013.
PMID: 23445717
Free PMC article.